Shanxi Zhendong Pharmaceutical Co.,Ltd (SHE:300158)
China
· Delayed Price · Currency is CNY 5.91
+0.01 (0.17%)
At close: Mar 10, 2026
SHE:300158 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 5,855 | 4,343 | 6,936 | 7,655 | 8,415 | 5,651 | Upgrade
|
| Market Cap Growth | 42.74% | -37.38% | -9.40% | -9.04% | 48.91% | 13.03% | Upgrade
|
| Enterprise Value | 5,066 | 2,529 | 4,612 | 5,035 | 8,202 | 5,093 | Upgrade
|
| Last Close Price | 5.90 | 4.32 | 6.75 | 7.45 | 6.24 | 4.08 | Upgrade
|
| PE Ratio | - | - | - | - | 3.22 | 21.57 | Upgrade
|
| PS Ratio | 2.01 | 1.46 | 1.91 | 2.05 | 1.65 | 1.17 | Upgrade
|
| PB Ratio | 1.61 | 1.19 | 1.35 | 1.47 | 1.05 | 1.00 | Upgrade
|
| P/TBV Ratio | 1.74 | 1.28 | 1.42 | 1.55 | 1.08 | 1.82 | Upgrade
|
| P/FCF Ratio | - | - | - | - | 63.37 | 148.78 | Upgrade
|
| P/OCF Ratio | - | - | - | 94.13 | 29.58 | 25.46 | Upgrade
|
| EV/Sales Ratio | 1.74 | 0.85 | 1.27 | 1.35 | 1.61 | 1.05 | Upgrade
|
| EV/EBITDA Ratio | - | - | 208.18 | 438.26 | 29.94 | 12.14 | Upgrade
|
| EV/EBIT Ratio | - | - | - | - | 55.11 | 20.12 | Upgrade
|
| EV/FCF Ratio | -6.12 | - | - | - | 61.77 | 134.07 | Upgrade
|
| Debt / Equity Ratio | 0.01 | 0.01 | 0.00 | 0.00 | 0.04 | 0.08 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 0.14 | 1.90 | 1.14 | 1.07 | Upgrade
|
| Debt / FCF Ratio | - | - | - | - | 2.36 | 11.78 | Upgrade
|
| Net Debt / Equity Ratio | -0.21 | -0.42 | -0.44 | -0.52 | -0.67 | -0.09 | Upgrade
|
| Net Debt / EBITDA Ratio | 1.50 | 2.92 | -101.37 | -236.55 | -19.63 | -1.16 | Upgrade
|
| Net Debt / FCF Ratio | 0.91 | 3.43 | 6.15 | 42.14 | -40.51 | -12.84 | Upgrade
|
| Asset Turnover | 0.56 | 0.53 | 0.57 | 0.45 | 0.58 | 0.67 | Upgrade
|
| Inventory Turnover | 1.99 | 1.84 | 1.61 | 1.88 | 2.34 | 2.57 | Upgrade
|
| Quick Ratio | 2.21 | 1.88 | 3.43 | 2.98 | 3.97 | 1.33 | Upgrade
|
| Current Ratio | 3.14 | 2.56 | 4.86 | 4.04 | 4.68 | 2.24 | Upgrade
|
| Return on Equity (ROE) | -31.03% | -30.28% | -0.92% | -0.86% | 38.13% | 4.58% | Upgrade
|
| Return on Assets (ROA) | -7.18% | -7.10% | -0.98% | -0.86% | 1.05% | 2.18% | Upgrade
|
| Return on Invested Capital (ROIC) | -21.85% | -25.26% | -3.68% | -4.42% | 3.19% | 3.97% | Upgrade
|
| Return on Capital Employed (ROCE) | -16.30% | -17.00% | -1.90% | -2.10% | 1.80% | 4.30% | Upgrade
|
| Earnings Yield | -23.03% | -30.59% | -0.63% | -0.67% | 31.10% | 4.64% | Upgrade
|
| FCF Yield | -14.14% | -10.32% | -5.27% | -0.84% | 1.58% | 0.67% | Upgrade
|
| Dividend Yield | - | - | - | - | 44.90% | 1.71% | Upgrade
|
| Payout Ratio | - | - | - | - | 7.45% | 29.87% | Upgrade
|
| Buyback Yield / Dilution | 5.47% | 0.38% | 0.02% | -0.04% | 0.01% | -0.01% | Upgrade
|
| Total Shareholder Return | 5.47% | 0.38% | 0.02% | -0.04% | 44.90% | 1.71% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.